ArticleScience immunology2020

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

Lakshmanane Premkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.